INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹-18 Cr | ₹0.15 Cr | ₹-19 Cr | ₹741 Cr | ₹814 Cr |
What is the latest Total Non-Current Liabilities ratio of INDSWIFT LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹-18 Cr |
| Mar2025 | ₹0.15 Cr |
| Mar2024 | ₹-19 Cr |
| Mar2023 | ₹741 Cr |
| Mar2022 | ₹814 Cr |
How is Total Non-Current Liabilities of INDSWIFT LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-18 Cr | Negative | |
| Mar2025 | ₹0.15 Cr | Positive | |
| Mar2024 | ₹-19 Cr | Negative | |
| Mar2023 | ₹741 Cr | -8.90 | |
| Mar2022 | ₹814 Cr | - | |
Compare Total Non-Current Liabilities of peers of INDSWIFT LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDSWIFT LABORATORIES | ₹3,089.6 Cr | -1.6% | -8.1% | 240.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹457,073.0 Cr | 8.1% | 9.3% | 9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹307,147.0 Cr | 10.5% | 18% | 51.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹181,626.0 Cr | 2.9% | 2.1% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,685.0 Cr | -0.1% | 16% | 14.6% | Stock Analytics | |
| CIPLA | ₹113,589.0 Cr | 1.4% | 8.1% | -6.8% | Stock Analytics | |
INDSWIFT LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDSWIFT LABORATORIES | -1.6% |
-8.1% |
240.3% |
| SENSEX | 5.5% |
13.3% |
-3.4% |
You may also like the below Video Courses